Neohesperidin dihydrochalcone: Presentation of a small molecule activator of mammalian alpha-amylase as an allosteric effector

FEBS Letters

Volumn 587, Issue 6, 2013, Pages 652-658

  Kashani Amin, Elaheh ^a   Larijani, Bagher ^a   Ebrahim Habibi, Azadeh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Activator; Alpha amylase; Inhibitor; Neohesperidin dihydrochalcone

Indexed keywords

ALPHA AMYLASE PANCREAS ISOENZYME; FLAVONOID; NEOHESPERIDIN DIHYDROCHALCONE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVATION; ENZYME ACTIVE SITE; HYDROPHILICITY; PRIORITY JOURNAL;

ALLOSTERIC REGULATION; ANIMALS; CATALYTIC DOMAIN; CHALCONES; ENZYME INHIBITORS; HESPERIDIN; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; KINETICS; MOLECULAR DOCKING SIMULATION; PANCREATIC ALPHA-AMYLASES; PROTEIN BINDING; SWEETENING AGENTS; SWINE;

MAMMALIA; SUS;

EID: 84875210274     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.01.022     Document Type: Article

References (51)

1. J.F. Robyt, and D. French The action pattern of porcine pancreatic alpha-amylase in relationship to the substrate binding site of the enzyme J. Biol. Chem. 245 1970 3917 3927
2. F.R. Bornet, A.M. Fontvieille, S. Rizkalla, P. Colonna, A. Blayo, C. Mercier, and G. Slama Insulin and glycemic responses in healthy humans to native starches processed in different ways: correlation with in vitro alpha-amylase hydrolysis Am. J. Clin. Nutr. 50 1989 315 323
3. X. Qin, L. Ren, X. Yang, F. Bai, L. Wang, P. Geng, G. Bai, and Y. Shen Structures of human pancreatic α-amylase in complex with acarviostatins: implications for drug design against type II diabetes J. Struct. Biol. 174 2011 196 202
4. A. Levitzki, and M.L. Steer The allosteric activation of mammalian α-amylase by chloride Eur. J. Biochem. 41 1974 171 180
5. G.D. Brayer Structural and mechanistic studies of chloride induced activation of human pancreatic α-amylase Protein Sci. 14 2005 743 755
6. N. Aghajari, G. Feller, C. Gerday, and R. Haser Structural basis of α-amylase activation by chloride Protein Sci. 11 2002 1435 1441
7. R. Maurus, A. Begum, L.K. Williams, J.R. Fredriksen, R. Zhang, S.G. Withers, and G.D. Brayer Alternative catalytic anions differentially modulate human alpha-amylase activity and specificity Biochemistry 47 2008 3332 3344
8. S. Numao, R. Maurus, G. Sidhu, Y. Wang, C.M. Overall, G.D. Brayer, and S.G. Withers Probing the role of the chloride ion in the mechanism of human pancreatic alpha-amylase Biochemistry 41 2002 215 225
9. S. D'Amico, C. Gerday, and G. Feller Structural similarities and evolutionary relationships in chloride-dependent alpha-amylases Gene 253 2000 95 105
10. S.H. Yoon, and J.F. Robyt Activation and stabilization of 10 starch-degrading enzymes by Triton X-100, polyethylene glycols, and polyvinyl alcohols Enzyme Microb. Tech. 37 2005 556 562
11. Kashani-Amin, E., Yaghmaei, P., Larijani, B. and Ebrahim-Habibi, A. (in press) Xanthine derivatives as activators of alpha-amylase: hypothesis on a link with the hyperglycemia induced by caffeine. Obes. Res. Clin. Pract. http://dx.doi.org/10.1016/j.orcp.2012.07.007.
12. J.L. Ferrer, M. Austin, C. Stewart Jr., and J. Noel Structure and function of enzymes involved in the biosynthesis of phenylpropanoids Plant Physiol. Biochem. 46 2008 356 370
13. E. Lo Piparo, H. Scheib, N. Frei, G. Williamson, M. Grigorov, and C.J. Chou Flavonoids for controlling starch digestion: structural requirements for inhibiting human α-amylase J. Med. Chem. 51 2008 3555 3561
14. G.D. Brayer, Y. Luo, and S.G. Withers The structure of human pancreatic α-amylase at 1.8 Å resolution and comparisons with related enzymes Protein Sci. 4 1995 1730 1742
15. S. D'Amico, C. Gerday, and G. Feller Structural similarities and evolutionary relationships in chloride-dependent α-amylases Gene 253 2000 95 105
16. M. Najafian, A. Ebrahim-Habibi, N. Hezareh, P. Yaghmaei, K. Parivar, and B. Larijani trans-Chalcone: a novel small molecule inhibitor of mammalian alpha-amylase Mol. Biol. Rep. 38 2010 1617 1620
17. G. DuBois, G. Crosby, and R. Stephenson Dihydrochalcone sweeteners. A study of the atypical temporal phenomena J. Med. Chem. 24 1981 408 428
18. G. DuBois, G. Crosby, R. Stephenson, and R. Wingard Dihydrochalcone sweeteners. Synthesis and sensory evaluation of sulfonate derivatives J. Agric. Food Chem. 25 1977 763 772
19. T. Grenby Intense sweeteners for the food industry: an overview Trends Food Sci. Tech. 2 1991 2 6
20. M. Winnig, B. Bufe, N. Kratochwil, J. Slack, and W. Meyerhof The binding site for neohesperidin dihydrochalcone at the human sweet taste receptor BMC Struct. Biol. 7 2007 66
21. K.M. Eny, T.M. Wolever, P.N. Corey, and A. El-Sohemy Genetic variation in TAS1R2 (Ile191Val) is associated with consumption of sugars in overweight and obese individuals in 2 distinct populations Am. J. Clin. Nutr. 92 2010 1501 1510
22. D. Sprous, and K.R. Palmer The T1R2/T1R3 sweet receptor and TRPM5 ion channel taste targets with therapeutic potential Prog. Mol. Biol. Transl. Sci. 91 2010 151 208
23. J.M. Choi, B.S. Yoon, S.K. Lee, J.K. Hwang, and R. Ryang Antioxidant properties of neohesperidin dihydrochalcone: inhibition of hypochlorous acid-induced DNA strand breakage, protein degradation, and cell death Biol. Pharm. Bull. 30 2007 324 330
24. J. Suarez, M. Herrera, and E. Marhuenda Hesperidin and neohesperidin dihydrochalcone on different experimental models of induced gastric ulcer Phytother. Res. 10 1996 616 618
25. K. Lorentz Evaluation of α-amylase assays with 4-nitrophenyl-a-d- oligosaccharides as substrates Clin. Chem. Lab. Med. 21 1983 463 471
26. P. Bernfeld, S. Colowick, and N. Kaplan Methods Enzymol 1 1955 149
27. R. Wisastra, M. Ghizzoni, A. Boltjes, H.J. Haisma, and F.J. Dekker Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases Bioorg. Med. Chem. 20 2012 5027 5032
28. A. Saboury, and M. Alijanianzadeh Ethyl xanthate and propyl xanthate as activators and inhibitors of mushroom tyrosinase in different concentrations J. Chin. Chem. Soc. 5 2008 937 942
29. V. Leskovac Comprehensive Enzyme Kinetics 2003 Springer
30. A. Saboury Enzyme inhibition and activation: a general theory J. Iran Chem. Soc. 6 2009 219 229
31. W. Cleland The statistical analysis of enzyme kinetic data Adv. Enzymol. Relat. Areas Mol. Biol. 29 1967 1 32
32. M. Alkazaz, V. Desseaux, G. Marchis-Mouren, F. Payan, E. Forest, and M. Santimone The mechanism of porcine pancreatic alpha-amylase. Kinetic evidence for two additional carbohydrate-binding sites Eur. J. Biochem./FEBS 241 1996 787
33. O. Trott, and A.J. Olson AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J. Comput. Chem. 31 2010 455 461
34. A. Grosdidier, V. Zoete, and O. Michielin SwissDock, a protein-small molecule docking web service based on EADock DSS Nucleic Acids Res. 39 2011 W270 W277
35. V. Desseaux, R. Koukiekolo, Y. Moreau, M. Santimone, and G. Marchis-Mouren Mechanism of porcine pancreatic alpha-amylase: inhibition of amylose and maltopentaose hydrolysis by various inhibitors Biol. Brat. 57 2002 163 170
36. D. Skrincosky, and C. Santangelo Working with enzymes Curr. Protoc. Essent. Lab. Tech. 2008 10.1.1 10.1.33 http://onlinelibrary.wiley.com/doi/10. 1002/9780470089941.et1001s00
37. M. Yoshino A graphical method for determining inhibition parameters for partial and complete inhibitors Biochem. J. 248 1987 815
38. P.D. Boyer The Enzymes Kinetics and Mechanism Vol. 2 1970 Academic Press 21
39. 50 J. Pharmacol. Toxicol. Methods 41 1999 55 58
40. G. Ferey-Roux, J. Perrier, E. Forest, G. Marchis-Mouren, A. Puigserver, and M. Santimone The human pancreatic [alpha]-amylase isoforms: isolation, structural studies and kinetics of inhibition by acarbose BBA-Protein Struct. Mol. Enzymol. 1388 1998 10 20
41. J.S. Kim, C.S. Kwon, and K.H. Son Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid Biosci. Biotechnol. Biochem. 64 2000 2458 2461
42. M.J. Kim Comparative study of the inhibition of [alpha]-glucosidase, [alpha]-amylase, and cyclomaltodextrin glucanosyltransferase by acarbose, isoacarbose, and acarviosine-glucose Arch. Biochem. Biophys. 371 1999 277 287
43. M. Al Kazaz, V. Desseaux, G. Marchis-Mouren, E. Prodanov, and M. Santimone The mechanism of porcine pancreatic alpha-amylase. Inhibition of maltopentaose hydrolysis by acarbose, maltose and maltotriose Eur. J. Biochem. 252 1998 100 107
44. C. Li, A. Begum, S. Numao, K.H. Park, S.G. Withers, and G.D. Brayer Acarbose rearrangement mechanism implied by the kinetic and structural analysis of human pancreatic α-amylase in complex with analogues and their elongated counterparts Biochemistry 44 2005 3347 3357
45. J.L. Rodgers, and W.A. Nicewander Thirteen ways to look at the correlation coefficient Am. Stat. 42 1988 59 66
46. A.M. Brzozowski Structural analysis of a chimeric bacterial α-amylase. High-resolution analysis of native and ligand complexes Biochemistry 39 2000 9099 9107
47. A. Ebrahim-Habibi Flavonoids as potential antihyperglycemics: an in silico study of their alpha-amylase inhibitory mode Drugs Future 33 Suppl. A 2008 306 307
48. J. Monod, J.P. Changeux, and F. Jacob Allosteric proteins and cellular control systems J. Mol. Biol. 6 1963 306 329
49. O. Hayes Griffith, G. Bruce Birrell, T.O. Zaikova, A.V. Rukavishnikov, and J.F.W. Keana Allosteric interactions within subsites of a monomeric enzyme: kinetics of fluorogenic substrates of PI-specific phospholipase C Biophys. J. 84 2003 3264 3275
50. D. Panagou, M.D. Orr, J.R. Dunstone, and R.L. Blakley A monomeric, allosteric enzyme with a single polypeptide chain. Ribonucleotide reductase of Lactobacillus leichmannii Biochemistry 11 1972 2378 2388
51. X.W. Yang, M.Z. Huang, Y.S. Jin, L.N. Sun, Y. Song, and H.S. Chen Phenolics from Bidens binnata and their amylase inhibitory properties Fitoterapia 83 2012 1169 1175